Skip to main content

Table 6 Predictors associated with physical component score of health-related quality of life for PLWHIV

From: The role of personality, social economic and prevention strategy effects on health-related quality of life among people living with HIV/AIDS

Characteristic

β

SE

Z-value

P-value

Strategy practice effect

 Strategy 1

–

–

–

–

 Strategy 2

− 2.753

1.617

− 1.700

0.089

 Strategy 3

− 0.357

1.611

− 0.220

0.825

 Strategy 4

1.345

2.266

0.590

0.553

Age (years)

 16–18

–

–

–

–

 18–30

− 0.660

2.297

− 0.290

0.774

 30–45

− 2.286

2.299

− 0.990

0.320

 45–60

− 4.030

2.303

− 1.750

0.080

 ≥ 60*

− 6.539

2.351

− 2.780

0.005

Race/ethnicity

 Han nationality

    

 Yi minority

0.328

0.626

0.520

0.600

 Zhuang minority

0.805

0.634

1.270

0.205

 Other minority ethnic group

0.302

0.506

0.600

0.551

Marital status

 Separated/Divorced/Unmarried

–

–

–

–

 Married/Cohabitating

0.593

0.362

1.640

0.102

Education level

 < 9 years

–

–

–

–

 ≥ 9 years

0.686

0.380

1.810

0.071

Occupation

 Workers

–

–

–

–

 Public officers/Staff member*

1.854

0.768

2.410

0.016

 Farmers

1.002

0.616

1.630

0.104

 Migrant workers

1.197

0.752

1.590

0.111

 Self-employed

0.149

0.700

0.210

0.831

 Unemployed

− 0.144

0.745

− 0.190

0.847

Household income per year (CNY)

 < 5000

–

–

–

–

 5000–10 000

0.470

0.440

1.070

0.285

 10 000–50 000*

0.997

0.464

2.150

0.032

 ≥ 50 000

1.625

1.096

1.480

0.138

HIV status known by others

 No one knowing

–

–

–

–

 Partially*

− 0.948

0.415

− 2.29

0.022

 All*

− 2.376

0.680

− 3.49

0.001

 No clear*

− 1.992

0.772

− 2.58

0.010

Initial infectious status

 HIV status

–

–

–

–

 AIDS status

0.162

0.398

0.410

0.684

Transmission model

 Heterosexual transmission

–

–

–

–

 Homosexual transmission

− 0.389

0.720

− 0.540

0.589

 Intravenous drug use*

− 2.083

0.540

− 3.860

0.001

 Mother-to-infant

− 3.974

2.117

1.880

0.060

 Unclear*

− 2.119

0.975

− 2.170

0.030

Duration of antiretroviral therapy

 ≤ 1 years

–

–

–

–

 1–2 years

− 0.296

0.720

− 0.410

0.681

 2–4 years

0.720

0.606

1.190

0.235

 ≥ 4 years

− 0.244

0.533

− 0.460

0.647

 Not yet

1.472

1.597

0.920

0.357

The most recent CD4 counts

 ≥ 500 cells/μl

–

–

–

–

 350–500 cells/μl

− 0.330

0.432

− 0.760

0.445

 200–350 cells/μl

0.188

0.478

0.390

0.694

 < 200 cells/μl *

− 2.046

0.663

− 3.090

0.002

Unclear

− 0.081

2.286

− 0.040

0.972

Social support*

0.086

0.026

3.340

0.001

Anxiety*

− 0.496

0.070

− 7.070

0.001

Depression*

− 0.080

0.069

− 2.980

0.003

  1. *P < 0.05. PLWHIV people living with HIV. Strategy1: the strategy with good practice; Strategy 2: the strategy with traditional advantage practice; Strategy 3: the strategy with advanced practice; Strategy 4: the strategy with the general practice